Related Experiment Video
Updated: Oct 26, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Emerging impact of quercetin in the treatment of prostate cancer
Soudeh Ghafouri-Fard1, Farnaz Aghazadeh Shabestari2, Saba Vaezi3
1Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:
Quercetin is a flavonoid agent detected in fruits and vegetables with anti-inflammatory, antioxidant, and anticancer effects. This flavonoid can suppress cell cycle transition and induce apoptosis in neoplastic cells. Therapeutic effects of quercetin have been assessed in diverse cancers including prostate cancer through the establishment of in vitro and in vivo experiments. Moreover, this agent might prevent the initiation of this type of cancer as it indirectly blocks the activity of promoters of two important genes in the pathogenesis of prostate cancer i.e. androgen receptor (AR) and prostate specific antigen (PSA). Several in vitro investigations have identified the differential influence of quercetin on normal prostate cells versus neoplastic cells, emphasizing its specific cytotoxic effects on cancerous cells. The most appreciated route of quercetin effect on prostate cancer cells is the detachment of Bax from Bcl-xL and the stimulation of caspase families. Besides, quercetin might enhance the effects of other therapeutic options against prostate cancer. For instance, a combination of TNF-related apoptosis-inducing ligand (TRAIL) and quercetin has been recommended as a novel modality for the treatment of prostate cancer. These kinds of strategies might overcome resistance to apoptosis in cancer cells. In the current paper, we summarize the recent data about the preventive and therapeutic influences of quercetin in prostate cancer.
Insights
Quercetin, a plant flavonoid, shows promise in preventing and treating prostate cancer by inducing cancer cell death and enhancing other therapies. It selectively targets neoplastic cells, offering a potential new avenue for prostate cancer management.
Area of Science:
- * Phytochemistry and Cancer Biology
- * Nutritional Oncology
Background:
- * Quercetin, a flavonoid found in fruits and vegetables, possesses anti-inflammatory, antioxidant, and anticancer properties.
- * It exhibits potential in suppressing cell cycle progression and inducing apoptosis in neoplastic cells, particularly relevant to prostate cancer.
- * Quercetin may play a role in preventing prostate cancer by inhibiting key genes like the androgen receptor (AR) and prostate specific antigen (PSA).
Purpose of the Study:
- * To review current research on the preventive and therapeutic applications of quercetin in prostate cancer.
- * To highlight quercetin's selective cytotoxic effects on cancerous prostate cells compared to normal cells.
- * To explore quercetin's mechanisms of action, including apoptosis induction and potential synergy with other treatments.
Main Methods:
- * Review of in vitro and in vivo experimental data on quercetin's effects on prostate cancer.
- * Analysis of studies investigating quercetin's impact on cell cycle regulation and apoptosis pathways.
- * Examination of research on quercetin's interaction with prostate cancer-related genes and therapeutic agents.
Main Results:
- * Quercetin demonstrates differential effects on normal versus neoplastic prostate cells, indicating specific cytotoxicity against cancer cells.
- * Its mechanism involves the modulation of apoptosis-related proteins (Bax, Bcl-xL) and the activation of caspase cascades.
- * Quercetin may enhance the efficacy of other prostate cancer treatments, such as TNF-related apoptosis-inducing ligand (TRAIL).
Conclusions:
- * Quercetin exhibits significant potential as both a preventive and therapeutic agent for prostate cancer.
- * Its ability to induce apoptosis and selectively target cancer cells warrants further investigation.
- * Combination therapies involving quercetin may offer novel strategies to overcome treatment resistance in prostate cancer.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Inhibition of Cdk Activity

